四环生物
(000518)
| 流通市值：31.30亿 | | | 总市值：31.30亿 |
| 流通股本：10.30亿 | | | 总股本：10.30亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 85,804,755.13 | 70,987,953.9 | 74,991,175.13 | 89,551,991.57 |
| 交易性金融资产 | 10,258,134.9 | 87,882 | 129,625.95 | 139,878.85 |
| 应收票据及应收账款 | 158,650,788.42 | 71,314,258.43 | 77,201,034.92 | 72,485,325.26 |
| 其中：应收票据 | 1,088,801.08 | 1,795,437.53 | 2,663,888.61 | 3,936,203.37 |
| 应收账款 | 157,561,987.34 | 69,518,820.9 | 74,537,146.31 | 68,549,121.89 |
| 应收款项融资 | 2,286,659.89 | 2,804,044.06 | 255,739.45 | 2,058,449.19 |
| 预付款项 | 9,002,855.37 | 1,187,137.1 | 1,144,012.89 | 356,371.47 |
| 其他应收款合计 | 1,371,659.94 | 1,206,753.83 | 1,178,077.79 | 1,112,156.36 |
| 存货 | 135,582,784.43 | 168,628,490.97 | 170,009,602.31 | 218,871,435.77 |
| 一年内到期的非流动资产 | 9,904,623.08 | 9,366,478.64 | 0 | 0 |
| 其他流动资产 | 4,070,605.6 | 33,393.2 | 221,273.11 | 129,498.91 |
| 流动资产合计 | 420,132,866.76 | 325,616,392.13 | 325,130,541.55 | 384,705,107.38 |
| 非流动资产: | | | | |
| 长期应收款 | 25,549,023.25 | 28,262,566.65 | 47,187,084.65 | 0 |
| 投资性房地产 | 23,744,579.44 | 24,549,056.55 | 25,353,533.63 | 26,158,010.71 |
| 固定资产 | 55,681,180.42 | 48,610,407.63 | 46,755,030.06 | 48,048,457.7 |
| 在建工程 | 543,979.63 | 370,528.3 | 518,928.3 | 148,400 |
| 使用权资产 | 19,129,435.66 | 16,944,753.02 | 18,198,827.57 | 18,887,968.66 |
| 无形资产 | 47,724,569.52 | 9,322,736.8 | 9,685,017.51 | 9,937,461.75 |
| 开发支出 | 7,912,440.02 | 0 | 0 | 0 |
| 商誉 | 63,044,693.7 | 0 | 0 | 0 |
| 长期待摊费用 | 1,456,163.79 | 0 | 0 | 0 |
| 递延所得税资产 | 16,585,244.37 | 5,930,941.89 | 6,381,318.86 | 6,157,263.58 |
| 其他非流动资产 | 28,400,000 | 0 | 0 | 0 |
| 非流动资产合计 | 289,771,309.8 | 133,990,990.84 | 154,079,740.58 | 109,337,562.4 |
| 资产总计 | 709,904,176.56 | 459,607,382.97 | 479,210,282.13 | 494,042,669.78 |
| 流动负债: | | | | |
| 短期借款 | 49,000,000 | 20,000,000 | 20,000,000 | 10,000,000 |
| 交易性金融负债 | 29,705,382.37 | 0 | 0 | 0 |
| 应付票据及应付账款 | 48,360,236.16 | 40,327,820.67 | 36,778,708.44 | 44,543,189.17 |
| 应付账款 | 48,360,236.16 | 40,327,820.67 | 36,778,708.44 | 44,543,189.17 |
| 预收款项 | 3,184,607.21 | 3,420,026.75 | 3,911,532.99 | 4,497,595.65 |
| 合同负债 | 44,016,470.81 | 9,712,054.27 | 14,344,841.15 | 12,125,450.55 |
| 应付职工薪酬 | 2,158,924 | 378,401.32 | 321,063.1 | 7,123,385 |
| 应交税费 | 5,220,151.53 | 5,563,894.2 | 5,172,024.12 | 5,684,956.29 |
| 其他应付款合计 | 54,352,911.15 | 481,538.32 | 638,989.35 | 619,856.74 |
| 一年内到期的非流动负债 | 42,536,185.41 | 5,217,565.23 | 5,222,091.53 | 5,044,099.4 |
| 其他流动负债 | 10,195,797.25 | 15,320,931.38 | 16,838,265.86 | 16,432,000.19 |
| 流动负债合计 | 288,730,665.89 | 100,422,232.14 | 103,227,516.54 | 106,070,532.99 |
| 非流动负债: | | | | |
| 长期借款 | 40,320,000 | 0 | 0 | 0 |
| 租赁负债 | 17,140,719.09 | 15,607,085.76 | 15,679,505.96 | 15,112,484.54 |
| 长期应付款 | 15,763,658.46 | 0 | 0 | 0 |
| 预计负债 | 12,576,793.39 | 12,576,793.39 | 13,139,919.81 | 13,413,504.73 |
| 递延收益 | 75,060 | 79,230 | 83,400 | 83,400 |
| 递延所得税负债 | 4,730,018.34 | 0 | 0 | 0 |
| 非流动负债合计 | 90,606,249.28 | 28,263,109.15 | 28,902,825.77 | 28,609,389.27 |
| 负债合计 | 379,336,915.17 | 128,685,341.29 | 132,130,342.31 | 134,679,922.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,029,556,222 | 1,029,556,222 | 1,029,556,222 | 1,029,556,222 |
| 资本公积 | 35,572,769.72 | 35,572,769.72 | 35,572,769.72 | 35,572,769.72 |
| 其他综合收益 | 613,212.14 | 613,212.14 | 613,212.14 | 613,212.14 |
| 盈余公积 | 37,856,747.22 | 37,856,747.22 | 37,856,747.22 | 37,856,747.22 |
| 未分配利润 | -817,487,915.12 | -794,811,153.19 | -780,291,705.77 | -768,977,935.77 |
| 归属于母公司股东权益合计 | 286,111,035.96 | 308,787,797.89 | 323,307,245.31 | 334,621,015.31 |
| 少数股东权益 | 44,456,225.43 | 22,134,243.79 | 23,772,694.51 | 24,741,732.21 |
| 股东权益合计 | 330,567,261.39 | 330,922,041.68 | 347,079,939.82 | 359,362,747.52 |
| 负债和股东权益合计 | 709,904,176.56 | 459,607,382.97 | 479,210,282.13 | 494,042,669.78 |
| 公告日期 | 2026-10-30 | 2026-08-21 | 2026-04-27 | 2026-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |